Apogee Therapeutics, Inc.
$134.97
+0.01 (+0.01%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +0.5%
- 3 Months
- +64.3%
- YTD
- +78.8%
- 1 Year
- +257.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 69.7%
- Largest decline max drawdown, since Aug 2025
- -24.6%
- Risk-adjusted return Sharpe ratio, 1-year
- 2.14
Own APGE?
See how APGE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.